| Kenneth Scott Backman, MD | |
|
55 Walls Dr, Ste. 405, Fairfield, CT 06824-5163 | |
| (203) 259-7070 | |
| (203) 254-7402 |
| Full Name | Kenneth Scott Backman |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 30 Years |
| Location | 55 Walls Dr, Fairfield, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174595847 | NPI | - | NPPES |
| 010038854CT02 | Other | CT | BLUE CROSS/BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 038854 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Care Of Fairfield County Llc | 4688579980 | 3 |
News Archive
Parents have been reading-;and sharing-;alarming reports of children who died or nearly died due to "dry drowning" over the past year. However, the use of that incorrect, nonmedical term has contributed to confusion about the true dangers of drowning in children and led to serious and fatal conditions being ignored after a "dry drowning" diagnosis was made, according to a special report in the June issue of Emergency Medicine News, published in the Lippincott portfolio by Wolters Kluwer.
The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.
WHO today committed to fast-track its assessment of new and existing quality contraceptives so more women in low- and middle-income countries can obtain and use a broader range of safe and effective contraceptive products.
A large meta-analysis, published in the open access journal BMC Medicine, has shown that snuff as used in Scandinavia has no discernible effect on the risk of various cancers. Products used in the past in the USA may have increased the risk, but any effect that exists now seems likely to be quite small.
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.
› Verified 2 days ago
| Entity Name | Allergy And Asthma Care Of Fairfield County Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710098645 PECOS PAC ID: 4688579980 Enrollment ID: O20031201000267 |
News Archive
Parents have been reading-;and sharing-;alarming reports of children who died or nearly died due to "dry drowning" over the past year. However, the use of that incorrect, nonmedical term has contributed to confusion about the true dangers of drowning in children and led to serious and fatal conditions being ignored after a "dry drowning" diagnosis was made, according to a special report in the June issue of Emergency Medicine News, published in the Lippincott portfolio by Wolters Kluwer.
The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.
WHO today committed to fast-track its assessment of new and existing quality contraceptives so more women in low- and middle-income countries can obtain and use a broader range of safe and effective contraceptive products.
A large meta-analysis, published in the open access journal BMC Medicine, has shown that snuff as used in Scandinavia has no discernible effect on the risk of various cancers. Products used in the past in the USA may have increased the risk, but any effect that exists now seems likely to be quite small.
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth Scott Backman, MD 55 Walls Dr, Ste. 405, Fairfield, CT 06824-5163 Ph: (203) 259-7070 | Kenneth Scott Backman, MD 55 Walls Dr, Ste. 405, Fairfield, CT 06824-5163 Ph: (203) 259-7070 |
News Archive
Parents have been reading-;and sharing-;alarming reports of children who died or nearly died due to "dry drowning" over the past year. However, the use of that incorrect, nonmedical term has contributed to confusion about the true dangers of drowning in children and led to serious and fatal conditions being ignored after a "dry drowning" diagnosis was made, according to a special report in the June issue of Emergency Medicine News, published in the Lippincott portfolio by Wolters Kluwer.
The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.
WHO today committed to fast-track its assessment of new and existing quality contraceptives so more women in low- and middle-income countries can obtain and use a broader range of safe and effective contraceptive products.
A large meta-analysis, published in the open access journal BMC Medicine, has shown that snuff as used in Scandinavia has no discernible effect on the risk of various cancers. Products used in the past in the USA may have increased the risk, but any effect that exists now seems likely to be quite small.
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.
› Verified 2 days ago
Irena Veksler-offengenden, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 55 Walls Dr, Ste. 405, Fairfield, CT 06824 Phone: 203-259-7070 Fax: 203-254-7402 | |
Dr. Katherine Alexis Bloom, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 55 Walls Dr, Suite 405, Fairfield, CT 06824 Phone: 203-259-7070 Fax: 203-254-7402 |